Quest Diagnostics (DGX) Tops Q4 EPS by 26c, Revenues Beat; Offers FY20 EPS/Revenue Outlook

Go back to Quest Diagnostics (DGX) Tops Q4 EPS by 26c, Revenues Beat; Offers FY20 EPS/Revenue Outlook
Quest Diagnostics (NYSE: DGX) Delayed: 197.15 +3.57 (1.84%)
Previous Close $193.58    52 Week High $86.85 
Open $195.78    52 Week Low $59.66 
Day High $197.79    P/E 37.13 
Day Low $194.15    EPS $5.31 
Volume 275,188